Wednesday, February 10, 2010, 9:11am EST - Canadian Markets open in 19 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Mylan, Inc. (MYL)

 On Feb 9: 17.68 USD   0.00 (0.00%)  
MORE ON MYL
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Mylan Inc. (NasdaqNM:MYL) Delayed quote dataEdit
Last Trade: 17.68 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 17.68
Open: N/A
Bid: 17.50 x 800
Ask: 17.90 x 500
1y Target Est: 21.00
Day's Range: N/A - N/A
52wk Range: 11.14 - 19.21
Volume: 0
Avg Vol (3m): 5,942,990
Market Cap: 5.40B
P/E (ttm): 108.47
EPS (ttm): 0.16
Div & Yield: N/A (N/A%)
Mylan, Inc. (MYL)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add MYL to Portfolio   Download Data

HEADLINES
• Mylan Awarded NABP-VAWD Accreditation for Its Primary North American Distribution Facility
PRNewswire (Tue 6:38pm)
• [$$] Rob's Wrap: The Big Picture on the Dow
at RealMoney by TheStreet.com (Mon, Feb 8)
• Earnings Growth Proves Drugmaker Made Right Moves
Investor's Business Daily (Thu, Feb 4)
• Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)
PRNewswire (Thu, Feb 4)
• Coverage initiated on Mylan Labs by Oppenheimer
Briefing.com (Wed, Feb 3)
• Cephalon Enters Generics Market
Zacks.com (Tue, Feb 2)
• Mylan Schedules Fourth Quarter 2009 Financial Results Conference Call and Live Webcast
PRNewswire (Tue, Feb 2)
• UPDATE - Obama budget plan calls for generic drugmaker fees
at Reuters (Mon, Feb 1)
• Mylan gets FDA approval for generic laxative
AP (Fri, Jan 29)
• Mylan Receives Approval for Generic Version of GoLytely(R)
PRNewswire (Fri, Jan 29)
• Generic Drugs and The 'Maris' Poll
at CNBC (Fri, Jan 29)
More Headlines for MYL...
ANALYST
EPS Est (next year) (Dec-09) : 1.27
EPS Est (in 2 years) (Dec-10) : 1.54
Avg Rec (current)*: 2.2
PEG Ratio: 0.80
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Mylan Inc. and its subsidiaries engage in the development, manufacture, marketing, licensing, and distribution of generic, brand, and branded generic pharmaceutical products and active pharmaceutical ingredients (APIs).

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices